A

Acer Therapeutics Inc
F:P6NA

Watchlist Manager
Acer Therapeutics Inc
F:P6NA
Watchlist
Price: 0.804 EUR Market Closed
Market Cap: 28.8m EUR

Operating Margin
Acer Therapeutics Inc

0%
Current
-1 548%
Average
6.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-24.6m
/
Revenue
0

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
Acer Therapeutics Inc
F:P6NA
28.8m EUR N/A
US
Eli Lilly and Co
NYSE:LLY
934.9B USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
484.1B USD
27%
CH
Roche Holding AG
SIX:ROG
251.1B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP
24%
CH
Novartis AG
SIX:NOVN
205B CHF
33%
US
Merck & Co Inc
NYSE:MRK
241.5B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
42%
IE
Endo International PLC
LSE:0Y5F
202.5B USD
11%
US
Pfizer Inc
NYSE:PFE
145.1B USD
29%
No Stocks Found

Acer Therapeutics Inc
Glance View

Market Cap
28.8m EUR
Industry
Pharmaceuticals

Acer Therapeutics, Inc. is a pharmaceutical company. The company is headquartered in Newton, Massachusetts and currently employs 35 full-time employees. The company went IPO on 2006-09-01. The Company’s pipeline includes four programs: ACER-001 (sodium phenylbutyrate), ACER-801 (osanetant), EDSIVO (celiprolol) and ACER-2820 (emetine). ACER-001 (sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders (UCDs) and Maple Syrup Urine Disease (MSUD); ACER-801 (osanetant) for the treatment of induced vasomotor symptoms (iVMS); EDSIVO (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; and ACER-2820 (emetine), a host-directed therapy against a variety of viruses, including cytomegalovirus, zika, dengue, ebola and COVID-19.

P6NA Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-24.6m
/
Revenue
0
What is the Operating Margin of Acer Therapeutics Inc?

Based on Acer Therapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top